MedTrace Logo

Effect of Darbepoetin in Contrast-induced Nephropathy

NCT01197235 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-11-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether the drug that produce red blood cells is effective in the prevention of kidney dysfunction after coronary angiography in patients with chronic kidney disease.

Conditions

Interventions

DRUG

darbepoetin-α

Infusion of darbepoetin-α 1.5 μg/kg will be performed 1 hour before angiography

DRUG

isotonic saline

Infusion of isotonic saline will be performed 1 hour before angiography

Sponsors & Collaborators

  • SMG-SNU Boramae Medical Center

    collaborator OTHER

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Ki Young Na, MD PhD · Seoul Ntional University Bundang Hospital, Seoul National University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197235 on ClinicalTrials.gov